Editas Medicine, Inc. EDIT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

47/100

3/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Editas Medicine, Inc. (EDIT), dont 21 achats et 28 ventes. Le total des achats d'initiés s'élève à $6.29M et le total des ventes d'initiés à $1.36M.

Les initiés notables ayant une activité récente comprennent O'neill Gilmore Neil, Burkly Linda, Parison Amy. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — EDIT

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-03-12	O'neill Gilmore Neil	CEO	Attribution de RSU	1,015,200	$2.54	$2.58M	1,015,200
2026-03-12	Burkly Linda	EVP, Chief Scientific Officer	Attribution de RSU	292,856	$2.54	$743.85K	292,856
2026-03-12	Parison Amy	SVP, Chief Financial Officer	Attribution de RSU	292,856	$2.54	$743.85K	292,856
2026-03-03	O'neill Gilmore Neil	CEO	Vente Informative	5,394	$2.02	$10.89K	263,693
2026-03-03	Burkly Linda	EVP, Chief Scientific Officer	Vente Informative	749	$2.02	$1.51K	68,028
2026-03-03	Parison Amy	SVP, Chief Financial Officer	Vente Informative	474	$2.02	$957.48	15,434
2025-12-03	O'neill Gilmore Neil	CEO	Vente Informative	5,603	$2.15	$12.06K	269,087
2025-12-03	Burkly Linda	EVP, Chief Scientific Officer	Vente Informative	713	$2.15	$1.54K	68,777
2025-12-03	Parison Amy	SVP, Chief Financial Officer	Vente Informative	461	$2.15	$992.58	15,908
2025-09-03	O'neill Gilmore Neil	CEO	Vente Informative	5,592	$2.60	$14.52K	274,690
2025-09-03	Burkly Linda	EVP, Chief Scientific Officer	Vente Informative	710	$2.60	$1.84K	69,490
2025-09-03	Parison Amy	SVP, Chief Financial Officer	Vente Informative	458	$2.60	$1.19K	16,369
2025-08-07	Parison Amy	SVP, Chief Financial Officer	Vente Informative	679	$2.58	$1.75K	16,827
2025-07-31	Burkly Linda	EVP, Chief Scientific Officer	Vente Informative	5,121	$2.49	$12.76K	64,398
2025-06-06	Hirsch Andrew	Director	Attribution de RSU	37,500	$1.91	$71.63K	37,500
2025-06-06	Hopfield Jessica	Director	Attribution de RSU	37,500	$1.91	$71.63K	37,500
2025-06-06	Connaughton Bernadette	Director	Attribution de RSU	37,500	$1.91	$71.63K	37,500
2025-06-06	Scadden David	Director	Attribution de RSU	37,500	$1.91	$71.63K	37,500
2025-06-06	Levy Elliott M.	Director	Attribution de RSU	37,500	$1.91	$71.63K	37,500
2025-06-03	O'neill Gilmore Neil	CEO	Vente Informative	15,192	$1.72	$26.2K	280,282
2025-06-03	Burkly Linda	EVP, Chief Scientific Officer	Vente Informative	726	$1.72	$1.25K	69,519
2025-06-03	Parison Amy	SVP, Chief Financial Officer	Vente Informative	446	$1.72	$768.90	17,506
2025-04-08	Parison Amy	SVP, Chief Financial Officer	Attribution de RSU	34,672	$0.98	$33.98K	34,672
2025-03-28	Parison Amy	SVP, Chief Financial Officer	Inconnu	145,548	$1.72	$250.34K	-
2025-03-08	Lucera Erick	EVP, Chief Financial Officer	Attribution de RSU	70,000	$1.72	$120.4K	70,000
2025-03-08	O'neill Gilmore Neil	CEO	Attribution de RSU	175,000	$1.72	$301K	175,000
2025-03-08	Burkly Linda	EVP, Chief Scientific Officer	Attribution de RSU	70,000	$1.72	$120.4K	70,000
2025-03-04	Lucera Erick	EVP, Chief Financial Officer	Vente Informative	4,109	$1.71	$7.03K	112,720
2025-03-04	O'neill Gilmore Neil	CEO	Vente Informative	16,632	$1.71	$28.45K	295,474
2025-03-04	Burkly Linda	EVP, Chief Scientific Officer	Vente Informative	2,891	$1.71	$4.95K	70,245
2024-12-03	O'neill Gilmore Neil	CEO	Vente Informative	1,618	$2.08	$3.36K	312,106
2024-12-03	Mei Baisong	EVP, Chief Medical Officer	Vente Informative	541	$2.08	$1.12K	133,354
2024-09-04	O'neill Gilmore Neil	CEO	Vente Informative	1,555	$3.42	$5.33K	313,724
2024-09-04	Mei Baisong	EVP, Chief Medical Officer	Vente Informative	518	$3.42	$1.77K	133,895
2024-07-25	Burkly Linda	EVP, Chief Scientific Officer	Vente Informative	11,886	$5.42	$64.37K	73,136
2024-07-19	Mei Baisong	EVP, Chief Medical Officer	Vente Informative	6,619	$5.21	$34.46K	134,413
2024-06-04	O'neill Gilmore Neil	CEO	Vente Informative	12,191	$5.50	$67K	315,279
2024-06-04	Mei Baisong	EVP, Chief Medical Officer	Vente Informative	511	$5.50	$2.81K	141,032
2024-05-30	Vaishnaw Akshay	Director	Attribution de RSU	25,000	$5.17	$129.25K	25,000
2024-05-30	Hirsch Andrew	Director	Attribution de RSU	25,000	$5.17	$129.25K	25,000
2024-05-30	Hopfield Jessica	Director	Attribution de RSU	25,000	$5.17	$129.25K	25,000
2024-05-30	Connaughton Bernadette	Director	Attribution de RSU	25,000	$5.17	$129.25K	25,000
2024-05-30	Reeve Emma	Director	Attribution de RSU	25,000	$5.17	$129.25K	25,000
2024-05-30	Scadden David	Director	Attribution de RSU	25,000	$5.17	$129.25K	25,000
2024-05-30	Chatterjee Meeta	Director	Attribution de RSU	25,000	$5.17	$129.25K	25,000
2024-05-30	Levy Elliott M.	Director	Attribution de RSU	25,000	$5.17	$129.25K	25,000
2024-05-20	Lucera Erick	EVP, Chief Financial Officer	Vente Informative	22,337	$5.61	$125.4K	116,829
2024-05-13	Hopfield Jessica	Director	Achat Informatif	45,000	$5.64	$253.87K	67,700
2024-03-05	O'neill Gilmore Neil	CEO	Vente Informative	77,824	$9.42	$732.88K	327,470
2024-03-04	Mei Baisong	SVP, Chief Medical Officer	Vente Informative	20,327	$9.42	$191.43K	141,543

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration